Prof. Rami Nassir - Cancer Genetics - Best Researcher Award

Pathology - School of Medicine - Umm AlQura University - Saudi Arabia

AUTHOR PROFILE

EARLY ACADEMIC PURSUITS:

Rami M. Nassir, Ph.D., embarked on his academic journey at the University of California, Davis, focusing on Comparative Pathology with a major in Human Genetics. His early academic pursuits set the stage for a distinguished career at the intersection of genetics, pathology, and complex diseases.

PROFESSIONAL ENDEAVORS:

Nassir has seamlessly integrated academia, research, and clinical practice. Currently serving as a Professor (since July 2022) at the School of Medicine, Umm Al-Qura University, he is actively engaged in providing lectures across various pathology courses, supervising laboratory research, and contributing to small clinical research projects.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Rami M. Nassir's research focus spans diverse areas, including whole-genome sequencing, molecular diagnostics,cancer genetics and clinical applications in genomic medicine. His significant contributions to various sequencing platforms and meta-analyses underscore his dedication to advancing genetic research methodologies.

IMPACT AND INFLUENCE:

Nassir's impact extends beyond academia into clinical practice. His involvement in diagnosing rare genetic diseases, implementing genomic medicine in diagnostic centers, and contributing to IVF procedures demonstrates the practical application of his research.

ACADEMIC CITES:

Being a member of prestigious genetic and medical societies such as the American Society of Human Genetics and the Saudi Society for Genomics and Molecular Oncology reflects Nassir's recognition in the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Nassir's legacy lies in his extensive research accomplishments, including his work in next-generation sequencing, meta-analyses, and population stratifications. His commitment to advancing research methodologies positions him as a trailblazer in the field.

RESEARCH ACCOMPLISHMENTS:

His proficiency in various genetic analysis techniques, from SNP genotyping to statistical analysis, highlights Nassir's comprehensive skill set and its application in contributing to major studies.

NOTABLE PUBLICATIONS

Racial and Ethnic Differences in Self-Reported COVID-19 Exposure Risks, Concerns, and Behaviors Among Diverse Participants in the Women's Health Initiative Study. 2023

Genetic control of mRNA splicing as a potential mechanism for incomplete penetrance of rare coding variants. 2023

A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk. 2023

Race and Ethnicity and Fracture Prediction among Younger Postmenopausal Women in the Women's Health Initiative Study. 2023

Associations of maternal preterm birth with subsequent risk for type 2 diabetes in women from the women's health initiative. 2023

Author Profile

EARLY ACADEMIC PURSUITS:

Linxi Zhu commenced her academic journey at Nanjing University, where she pursued a Bachelor's degree from July 2015 to June 2020. Following her undergraduate studies, she continued her academic pursuit at the same institution, earning a Master's degree from July 2020 to June 2021. Linxi Zhu then advanced further in her educational journey, undertaking a Ph.D. program at Nanjing University from July 2021 to June 2023.

PROFESSIONAL ENDEAVORS:

Since September 2023, Linxi Zhu has been serving as a Surgeon at Nanjing Drum Tower Hospital, marking a significant transition from academic pursuits to practical application in the field of surgery.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS :

Linxi Zhu's research has made notable contributions to the field of cancer genetics. Notably, her work titled "Loss of Claudin-1 incurred by DNMT aberration promotes pancreatic cancer progression" (published in Cancer Lett., 2024) sheds light on the molecular mechanisms underlying pancreatic cancer progression. Additionally, she has contributed to the development and validation of a nomogram for predicting post-operative abdominal infection in patients undergoing pancreaticoduodenectomy, as well as exploring the role of preoperative biliary drainage in postoperative outcomes after pancreaticoduodenectomy.

IMPACT AND INFLUENCE:

Zhu's research impact extends beyond pancreatic cancer, with contributions to the field of intrahepatic cholangiocarcinoma. Her collaborative work on high endothelial venule as a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma (published in Cell Prolif., 2023) underscores her diverse research interests.

ACADEMIC CITES:

Linxi Zhu has published in reputable journals, evident from her publications in Cancer Lett., Clin Chim Acta, Gland Surg, Cell Prolif., and Front Oncol. The citations received for her work demonstrate its scholarly significance and recognition within the academic community.

LEGACY AND FUTURE CONTRIBUTIONS:

Zhu's legacy lies in her comprehensive understanding of pancreatic cancer and related surgical interventions. Her research on individualized chemotherapy combined with sequential immunotherapy based on BRCA1 mRNA expression level in unresectable pancreatic cancer showcases innovative approaches. Looking forward, Linxi Zhu is poised to contribute further to the field, leaving a lasting impact on surgical and oncological research.